​

Prime Medicine (PRME) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Prime Medicine Revenue Highlights

Latest Revenue (Y)

$4.63M

Latest Revenue (Q)

$1.23M

Main Segment (Y)

Reportable Segment

Prime Medicine Revenue by Period

Prime Medicine Revenue by Year

DateRevenueChange
2025-12-31$4.63M55.28%
2024-12-31$2.98M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$5.21M100.00%
2019-12-31--

Prime Medicine generated $4.63M in revenue during NA 2025, up 55.28% compared to the previous quarter, and up 88.91% compared to the same period a year ago.

Prime Medicine Revenue by Quarter

DateRevenueChange
2025-09-30$1.23M9.87%
2025-06-30$1.11M-23.31%
2025-03-31$1.45M-33.39%
2024-12-31$2.18M944.50%
2024-09-30$209.00K100.00%
2024-06-30--100.00%
2024-03-31$591.00K100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30--100.00%
2021-06-30$9.13M100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2019-12-31--

Prime Medicine generated $1.23M in revenue during Q3 2025, up 9.87% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Prime Medicine Revenue Breakdown

Prime Medicine Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24
Reportable Segment$4.63M$2.98M

Prime Medicine's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25
Reportable Segment$838.00K$1.23M$1.11M$1.45M

Prime Medicine's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).

Prime Medicine Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
VIRVir Bio$68.56M$240.00K
KURAKura Oncology$67.48M$20.75M
MRVIMaravai LifeSciences$49.87M$41.63M
SEPNSepterna$45.95M$21.50M
EYPTEyePoint Pharmaceuticals$31.37M$966.00K
PRMEPrime Medicine$4.63M$1.23M
PROKProKidney$76.00K$217.00K
RZLTRezolute--
REPLReplimune Group--
BCAXBicara Therapeutics--
TYRATyra Biosciences--

PRME Revenue FAQ

What is Prime Medicine’s yearly revenue?

Prime Medicine's yearly revenue for 2025 was $4.63M, representing an increase of 55.28% compared to 2024. The company's yearly revenue for 2024 was $2.98M, representing an increase of 100.00% compared to 2023. PRME's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Prime Medicine’s quarterly revenue?

Prime Medicine's quarterly revenue for Q3 2025 was $1.22M, a 9.87% increase from the previous quarter (Q2 2025), and a 486.12% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $1.12M, a -23.31% decrease from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). PRME's quarterly revenue for Q1 2025 was $1.45M, a -33.39% decrease from the previous quarter (Q4 2024), and a 146.02% increase year-over-year (Q1 2024).

What is Prime Medicine’s revenue growth rate?

Prime Medicine's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.

What are Prime Medicine’s revenue streams?

Prime Medicine's revenue streams in c 25 are Reportable Segment

What is Prime Medicine’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Prime Medicine was Reportable Segment. This segment made a revenue of $4.63M, representing 100.00% of the company's total revenue.